Showing results (401-410 of 776) with videos related to

Sort By:
Pageof 78
American Journal of Obstetrics and Gynecology|August 1, 1989
Predictive value of increased plasma levels of fibronectin in gestational hypertensionV Ballegeer, B Spitz, L Kieckens, et al.
European Journal of Biochemistry|February 15, 1988
Enzymatic properties of single-chain and two-chain forms of a Lys158----Glu158 mutant of urokinase-type plasminogen activatorH R Lijnen, B Van Hoef, L Nelles, et al.
The Journal of Biological Chemistry|July 25, 1992
Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate responseK A Descheemaeker, S Wyns, L Nelles, et al.
Blood|August 1, 1988
Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cellsL A Miles, E G Levin, J Plescia, et al.
Circulation|November 1, 1990
Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis modelD Collen, M Dewerchin, H J Rapold, et al.
Human Gene Therapy|May 26, 1999
Percutaneous adenoviral gene transfer into porcine coronary arteries: is catheter-based gene delivery adapted to coronary circulation?O Varenne, R D Gerard, P Sinnaeve, et al.
Thrombosis and Haemostasis|October 31, 1988
Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activatorH R Lijnen, L Nelles, B Van Hoef, et al.
Biochimica Et Biophysica Acta|April 21, 1982
Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cellsK Bykowska, E G Levin, D C Rijken, et al.
European Journal of Biochemistry|April 15, 1992
Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with AlaH R Lijnen, X K Li, L Nelles, et al.
Thrombosis and Haemostasis|April 8, 1988
Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activatorD C Stump, E J Topol, A B Chen, et al.
Pageof 78